{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:50:04Z","timestamp":1787507404024,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.amjcard.2023.09.110","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:28:56Z","timestamp":1698146936000},"page":"249-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure"],"prefix":"10.1016","volume":"210","author":[{"given":"Sara","family":"Kalantari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-3713","authenticated-orcid":false,"given":"Daniel","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Medvedofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tayazime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Raikhelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.09.110_bib0001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.15420\/cfr.2016:1:1","article-title":"The mechanism of action of LCZ696","volume":"2","author":"Menendez","year":"2016","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0002","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2014-306775","article-title":"The neprilysin pathway in heart failure: a review and guide on the use of sacubitril\/valsartan","volume":"102","author":"Jhund","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0003","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0004","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0006","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro\u2013B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccl.2013.09.002","article-title":"The renin-angiotensin-aldosterone system and heart failure","volume":"3","author":"Sayer","year":"2014","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0009","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2015.01.033","article-title":"The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure","volume":"65","author":"Braunwald","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0010","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1161\/hc3001.094733","article-title":"Manipulation of the renin-angiotensin system","volume":"104","author":"Givertz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0011","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJM197004232821707","article-title":"Compensatory mechanisms in congestive heart failure\u2013the role of the peripheral resistance vessels","volume":"282","author":"Zelis","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0013","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0014","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0002-9149(74)90149-0","article-title":"Relation of left ventricular shape, function and wall stress in man","volume":"34","author":"Gould","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0735-1097(89)90504-4","article-title":"Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy","volume":"13","author":"Douglas","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0016","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.amjcard.2010.04.044","article-title":"Serial changes in left ventricular shape following early mitral valve repair","volume":"106","author":"Maffessanti","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0017","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jcmg.2017.08.023","article-title":"2D and 3D echocardiography-derived indices of left ventricular function and shape: relationship with mortality","volume":"11","author":"Medvedofsky","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchf.2016.11.012","article-title":"Left ventricular architecture, long-term reverse remodeling, and clinical outcome in mild heart failure with cardiac resynchronization: results from the REVERSE trial","volume":"5","author":"St John Sutton","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","article-title":"Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril","volume":"89","author":"St John Sutton","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrcardio.2017.139","article-title":"Reverse remodelling and myocardial recovery in heart failure","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0022","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jchf.2020.06.020","article-title":"Sacubitril\/Valsartan: neprilysin inhibition 5 years after PARADIGM-HF","volume":"8","author":"Docherty","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"18","key":"10.1016\/j.amjcard.2023.09.110_bib0023","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0735-1097(21)02018-0","article-title":"Effect of SACUBITRIL\/VALSARTAN on electrical and structural reverse remodeling in patients with heart failure with reduced ejection fraction","volume":"77","author":"Abudan","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0024","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.jacc.2018.07.102","article-title":"Sacubitril\/Valsartan averts adverse post-infarction ventricular remodeling and preserves systolic function in rabbits","volume":"72","author":"Torrado","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchf.2020.09.014","article-title":"Reverse cardiac remodeling following initiation of Sacubitril\/Valsartan in patients with heart failure with and without diabetes","volume":"9","author":"Khan","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0026","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11897-021-00501-6","article-title":"Reverse cardiac remodeling and ARNI therapy","volume":"18","author":"Abboud","year":"2021","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0028","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.amjcard.2023.09.110_bib0029","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jchf.2013.04.009","article-title":"Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure","volume":"1","author":"Uriel","year":"2013","journal-title":"JACC Heart Fail"}],"updated-by":[{"DOI":"10.1016\/j.amjcard.2023.12.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923011190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923011190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T08:43:40Z","timestamp":1702543420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923011190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":29,"alternative-id":["S0002914923011190"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.09.110","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.09.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}